Purpose To assess qualitative corneal changes and penetration of pulsed and continuous light accelerated crosslinking by in vivo confocal microscopy and corneal OCT. Methods A total of 20 patients affected from progressive keratoconus were enrolled in the study. Ten eyes of 10 patients underwent an epithelium-off pulsed-light accelerated corneal collagen crosslinking (PL-ACXL) by the KXL UV-A source (Avedro Inc.) with 8 min (1 s on/1 s off) of UV-A exposure at 30 mW/cm 2 and energy dose of 7.2 J/cm 2
Introduction
Riboflavin UV-A-induced corneal collagen crosslinking (CXL) represents a relatively new procedure available for the conservative treatment of progressive keratoconus 1,2 and secondary corneal ectasia 3 because of its capacity in increasing biomechanical corneal resistance 4, 5 and intrinsic anticollagenase activity. 6 The physicochemical basis of crosslinking lies in the photo-dynamic type I-II reactions 7 induced by the interaction between 0.1% riboflavin molecules absorbed in corneal tissue and UV-A rays delivered at 3 mW/cm 2 for 30 min (5.4 J/cm 2 energy dose) releasing reactive oxygen species (ROS) that mediated crosslink formation between and within collagen fibers. 8, 9 Conventional epithelium-off crosslinking (CXL) demonstrated its safety and long-term efficacy in stabilizing progressive keratoconus and secondary ectasias in different clinical trials. [10] [11] [12] [13] [14] On the other hand, the procedure is time consuming, lasting from 40 min to 1 h. 15 The Bunsen-Roscoe's law of reciprocity [16] [17] [18] theoretically demonstrated that the photochemical process behind crosslinking depends on the absorbed UV-A energy and its biological effect is proportional to the total energy dose delivered in the tissue. [16] [17] [18] According to this concept, it is theoretically possible to deliver the same energy dose ensuring a proportional biological effect by setting different UV-A powers and exposure times in order to accelerate and shorten the crosslinking procedure in accelerated crosslinking (ACXL) modality. [17] [18] [19] According to photochemical crosslinking studies based on kinetics model 7 the UV-A illumination caused a rapid depletion of oxygen in a riboflavin-soaked cornea and turning the UV light off led to replenishment of the oxygen to its original level within 3 to 4 min. 7 Krueger et al 20 and Herekar 21 have also observed a rapid oxygen depletion during corneal crosslinking with riboflavin and concluded that the ROS and, specifically, singlet oxygen are the predominant CXL reaction drivers. Under aerobic conditions, which are present during the first 10 to 15 s of UV-A exposure, sensitized photooxidation of the substrate (proteoglycan core proteins 22 and collagen in the corneal matrix) occurs mainly by its reaction with photochemically generated ROS, such as singlet molecular oxygen. This is consistent with a type II photochemical mechanism. After the first 10 to 15 s, oxygen becomes totally depleted and the reaction between the substrate and riboflavin becomes consistent with a predominantly type I photochemical mechanism. 7 Pulsing the UV light during crosslinking treatment theoretically restarts the photodynamic type II reaction achieving an additional oxygen concentration allowing more singlet oxygen release for crosslinking of collagen molecules. We report an in vivo scanning laser confocal microscopy and anterior chamber spectral domain OCT micro-morphological analysis in a series of 20 patients with progressive keratoconus investigating the qualitative corneal changes and estimating the penetration of pulsed light accelerated crosslinking (PL-ACXL) and continuous light accelerated crosslinking (CL-ACXL).
Materials and Methods
After Institutional Review Board of the Siena University Hospital approval and specific informed consent subscription, 20 patients affected from progressive keratoconus were enrolled in the study. They were divided into two treatment groups: 10 eyes of 10 patients (pulsed light treatments), age between 13 and 26 years (mean 21. After epithelium removal by a blunt metal spatula in a 9-mm circle, the cornea was imbibed for 10 min, [23] [24] [25] administering 3-5 drops of dextran-free riboflavin 0.1% with hydroxyl-propyl-methylcellulose (VibeX Rapid, Avedro Inc.) 23, 24 at 1 min interval, covering all corneal surface, including the limbus. Before starting UV-A irradiation, corneal thickness was checked by intraoperative optical OCT corneal pachymetry to ensure a constant minimum stromal thickness of 350 mm. 26 The riboflavin solution was administered along the UV-A exposure at 2.5 min intervals. At the end of the procedures, treated eyes were dressed by a soft contact lens bandage for 3 days and medicated with ciprofloxacin eye drops, diclofenac, and sodium hyaluronate eye drops 4 times/day. Postoperative in vivo qualitative analysis of corneal changes was assessed by the HRT II system (Rostock Cornea Module, Heidelberg, Germany) in vivo scanning laser confocal microscopy (IVCM) and spectral domain (SD) corneal OCT (Cirrus, Zeiss Meditec, Jena, Germany), estimating treatment penetration.
Inclusion criteria
The parameters we considered to establish keratoconus progression and inclusion criteria for each group were: worsening of UCVA/BSCVA 40.5 decimal equivalents, increase of Sph/Cyl 40.5 D, increase of topographic symmetry index SAI/SI 40.5 D, increase of simulated maximum K reading 41 D, reduction of the thinnest point at corneal OCT optical pachymetry Z10 mm, clear cornea at biomicroscopic examination, and absence of reticular dark striations at confocal laser microscopy in vivo. We considered relevant for the inclusion in the treatment protocol the variation of at least three of the parameters listed above (one clinical plus two instrumental) in the past 6 months of observation. All patients had a corneal thinnest point over 400 mm without epithelium. The following examinations were performed before and after the operation: in vivo scanning laser confocal microscopy (HRT II, Rostock Cornea Module) and anterior segment OCT analysis (Visante OCT, Zeiss Meditec) to assess qualitative ACXLinduced corneal changes and treatment penetration.
Results

PLA-XL
All eyes re-epithelialized by 3 days of therapeutic soft contact lens bandage. Epithelial stratification improved in time, being complete at month 3. Subepithelial and anterior stromal nerves disappeared immediately after treatment. Nerve regeneration started 1 month after (Figure 1a ). Confocal data of increased stromal reflectivity and demarcation line (defined by corneal edema and keratocytes apoptosis with changes in stromal reflectivity) were established by anterior chamber OCT at a mean depth of 180 mm (range 180-210 mm; Figure 1b ). The demarcation line was also clinically evident after pulsed light treatment at slit lamp examination ( Figure 1c) . No postoperative endothelial damage or cell loss was detected after pulsed light ACXL.
CLA-XL
Epithelial regrowth and nerve regeneration were similar with those observed in pulsed light epithelium-off treatments. Whereas epithelium regenerates rapidly into 3 days, neural flocculation was detectable 1 month after treatment. Stromal healing revealed a lower reflectivity than in pulsed light treatments. An uneven demarcation line is detectable by confocal microscopy at a mean depth of 160 mm (range 150-180 mm; Figure 2a ). Demarcation line depth was confirmed by corneal OCT at a mean depth of 160 mm (range 140-180 mm; Figure 2b) , also visible at slit lamp examination (Figure 2c 
Conclusions
In vivo scanning laser confocal microscopy allowed a precise qualitative analysis of the cornea after epithelium-off PL-ACXL and CL-ACXL treatments. Corneal changes included time-dependent epithelial stratification, nerves disappearance and regeneration, keratocytes loss with progressive repopulation, and stromal healing. Corneal OCT scans provided an insight in the identification of demarcation lines estimating approximately treatment's penetration. PL-ACXL showed an apoptotic effect meanly at 200 mm of stromal depth (range 190-240 mm), whereas CL-ACXL revealed a penetration of 160 mm on average (range 150-200 mm), both at confocal and corneal OCT analysis, that appeared inferior (approximately À 40 mm) to pulsed light. These findings were slightly better than those recently reported in literature, 29 probably because of the higher energy dose used in these treatments (7.2 J/cm 2 instead of 5.4 J/cm 2 ) and pulsed light modality. Indeed, pulsing the UV-A light inducing an intraoperative oxygen reuptake while prolonging treatment time at 8 min may influence a deeper penetration of oxidative damage. 30 The clinical aspect of the corneas after ACXL was good in both groups after therapeutic soft contact lens removal without complications. A demarcation line was detectable at slit lamp examination after therapeutic soft contact lens removal, as shown in Figures 1c and 2c . ACXL with pulsed (PL-ACXL) and continuous UV-A light illumination (CL-ACXL) reached the anterior midpart of the corneal stroma until a maximum of 240 mm and 200 mm of depth, respectively, measured from epithelium surface. This aspect assumes a physicochemical relevance because, as reported in literature, 31 the most important biomechanical effect related to crosslinking is concentrated in the anterior mid-stroma. To date, we do not know exactly the optimal interactions between UV-A energy, riboflavin concentration, and exposure time in order to obtain the maximum crosslinking effect ensuring a long-lasting (possibly a definitive) keratoconus biomechanical stability and the better functional outcome, even if the necessity to improve and shorten the procedure are highly desirable. Conventional epithelium-off CXL procedure (Riboflavin 0.1% plus dextran 20%, UV-A 3 mW/cm 2 ¼ 5.4 J/cm 2 for 30 min) was proved to be safe and efficacious in the conservative treatment of earlystage progressive keratoconus. Anyway, in our preliminary experience, the ACXL with epithelium removal demonstrated its safety for endothelium in both pulsed and continuous light treatment modalities, shortening the CXL procedure time under 20 min, and being well tolerated by patients. Pulsed light treatment seems slightly more capable to penetrate deeper in the corneal stroma as compared with continuous light treatment. Pulsed and continuous light ACXL represent evolving crosslinking procedures in order to achieve keratoconus stabilization in a short treatment time. The efficacy of these techniques needs to be determined in the mid-to long-term follow-up and in a large cohort of patients. K Clinical efficacy of ACXL needs to be determined in the mid-to long-term follow-up.
